Spots Global Cancer Trial Database for egfr mutated
Every month we try and update this database with for egfr mutated cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. | NCT02470065 | Non Small Cell ... | Afatinib Immediate surge... | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study | NCT03381274 | Carcinoma, Non-... | Oleclumab Osimertinib AZD4635 | 18 Years - 101 Years | MedImmune LLC |